Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Eastern Health | OTHER |
| Monash University | OTHER |
| Deakin University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Australia has one of the highest rates of methamphetamine use in the world; however, uptake of face-to-face psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and structural (e.g. service availability, geography) barriers to accessing care. Addressing these barriers through the provision of alternative treatment delivery models is imperative, particularly as effective and earlier intervention is likely to reduce the need for more costly and intensive treatment resulting from escalating methamphetamine use.
In this project, the investigators will conduct the first double-blind, parallel-group, randomised controlled trial (RCT) examining the effectiveness of the structured telephone-delivered intervention, Ready2Change (R2C), among participants with methamphetamine use problems (R2C-M). Cost effectiveness of R2C-M will also be investigated. Factors influencing program implementation will be evaluated to inform the scalability of this intervention for practice nationally, and for replication internationally.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| R2C-M intervention | Experimental | R2C-M telephone intervention - Six approximately weekly sessions of R2C-M telephone-delivered intervention (50 minutes in duration), delivered by the same R2C-M Counsellor each session (a qualified clinical psychologist trained in the R2C protocol by the developer, Dr Kate Hall). Call duration will be recorded. Sessions will be digitally recorded, and an independent researcher will randomly select and rate fidelity of intervention sessions for 20% of participants. R2C-M workbooks - Two workbooks to facilitate counsellor-delivered exercises within sessions, and between-session practice, will be mailed/emailed to participants. Self-help booklet - (as in control group) R2C-M participants will also receive a booklet of information and self-help strategies for methamphetamine use problems. |
|
| Control | Active Comparator | Self-help booklet - Control participants will receive (by mail/email) a booklet of information and self-help strategies for methamphetamine use problems. Telephone check-ins + information on further support - (to control for frequency of contact across treatment arms) Participants in this group will receive 6 telephone calls from the research team (lasting maximum 5 minutes, call duration will be recorded). During these calls, participants will be asked about their use of the booklet. Whenever required, the researcher will provide participants with information on further support (e.g. DirectLine or other state/territory AOD helpline for advice or referral). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| R2C-M | Behavioral | R2C-M comprises 12 modules addressing core practice elements and skills from evidence-based cognitive and behavioural interventions. Modules include: (i) self-monitoring, goal setting and behaviour change skills; (ii) identification of strengths and motivational enhancement; (iii) relapse prevention; (iv) psychoeducation and harm reduction; (v) emotion regulation skills; (vi) anger management skills; (vii) urges and cravings management skills; (viii) sleep hygiene skills; (ix) mindfulness skills; (x) interpersonal skills; (xi) anxiety management skills; (xii) depressed mood management skills. The R2C-M workbooks contain psychoeducation and intervention exercises, to facilitate counsellor-delivered exercises within sessions, and between-session practice. |
| Measure | Description | Time Frame |
|---|---|---|
| Methamphetamine problem severity | Change in methamphetamine problem severity (Drug Use Disorders Identification Test; DUDIT) | 3-months post-randomisation |
| Measure | Description | Time Frame |
|---|---|---|
| Methamphetamine problem severity | Change in methamphetamine problem severity (DUDIT) | 6- and 12-months post-randomisation |
| Number of methamphetamine use days | Change in number of methamphetamine use days (Timeline Followback; TLFB) |
| Measure | Description | Time Frame |
|---|---|---|
| Program evaluation | Mixed-methods program evaluation (Glasgow et al.'s RE-AIM framework) | Through study completion, approximately 28 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dan I Lubman | Turning Point, Eastern Health; Monash University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Turning Point | Richmond | Victoria | 3121 | Australia |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36991490 | Derived | Lubman DI, Manning V, Arunogiri S, Hall K, Reynolds J, Stragalinos P, Petukhova R, Gerhard R, Tyler J, Bough A, Harris A, Grigg J. A structured, telephone-delivered intervention to reduce methamphetamine use: study protocol for a parallel-group randomised controlled trial. Trials. 2023 Mar 29;24(1):235. doi: 10.1186/s13063-023-07172-9. |
Not provided
Not provided
No Ethics approval to seek patient permission to share data outside this study, other than for related projects conducted by the research team.
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| SAP | No | Yes | No | Statistical Analysis Plan | Aug 1, 2025 | Aug 3, 2025 | SAP_000.pdf |
Not provided
Randomised controlled trial
Not provided
Not provided
Not provided
|
| Self-help booklet | Other | A booklet of information and self-help strategies for methamphetamine use problems. |
|
| 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Amount of methamphetamine used | Change in amount of methamphetamine used (TLFB) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Number of DSM-5 methamphetamine use disorder criteria met | Change in the number of DSM-5 methamphetamine use disorder criteria met (Structured Clinical Interview for DSM-5 Disorders - Research Version; SCID-5-RV) | 3-, 6- and 12-months post-randomisation |
| Methamphetamine craving | Change in craving for methamphetamine (Craving Experience Questionnaire; CEQ) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Psychological functioning | Change in psychological functioning (Depression Anxiety and Stress Scale; DASS-12) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Psychotic-like experiences | Change in psychotic-like experiences (Community Assessment of Psychic Experiences 15, CAPE15) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Quality of life | Change in quality of life (EUROHIS-QOL single item) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Days of other drug use | Change in days of other drug use (TLFB) | 6 weeks, and 3-, 6- and 12-months post-randomisation |
| Cost-effectiveness - QALYs | Difference in quality-adjusted life years (QALYs) (abridged version of the 5-level EQ-5D version, EQ-5D-5L+) | Over 12 months |
| Cost-effectiveness - health care costs | Difference in health care costs (3Mg Health-care Resource Use Questionnaire) | Over 12 months |
| Cost-effectiveness - work-related losses | Difference in work-related losses (World Health Organization Health and Performance Questionnaire Clinical Trials Version; WHO HPQ28-Day) | Over 12 months |
| Adverse events | Occurrence of adverse events (AEs) and significant adverse events (SAEs) | Up to 6 weeks post-randomisation |